Director, CDER Patient Focused Drug Development Program, US Food and Drug Administration
U.S. Food and Drug Administration (FDA)
Robyn Bent is the Director of the Patient-Focused Drug Development (PFDD) Program in the Center for Drug Evaluation and Research (CDER). PFDD is an effort to systematically obtain patient input and facilitate the incorporation of meaningful patient input into drug development and regulatory decision making. Prior to joining FDA, Robyn held several positions at the National Institutes of Health. She has extensive experience in clinical trial design, conduct, and oversight. Robyn earned her Bachelor of Science in Nursing from The Catholic University of America and her Master of Science degree from the George Washington University.
Wednesday, October 8, 2025
4:30 PM - 5:30 PM EST
Is it Time for a New Patient Experience Data Section in Product Labeling?
Thursday, October 9, 2025
3:15 PM - 4:15 PM EST